Isocitrate Dehydrogenase Inhibitors Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: ID84CDF4EAB2EN
Market Monitor Global

Abstracts

Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (?-ketoglutarate) and CO2.

This report contains market size and forecasts of Isocitrate Dehydrogenase Inhibitors in Global, including the following market information:

Global Isocitrate Dehydrogenase Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Isocitrate Dehydrogenase Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

IDH1 Mutant Medullary Malignant Tumor Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Isocitrate Dehydrogenase Inhibitors include AGIOS, Aslan Pharmaceuticals, Bayer, Beigene, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Philogen S.p.A. and Tesaro, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Isocitrate Dehydrogenase Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Isocitrate Dehydrogenase Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Isocitrate Dehydrogenase Inhibitors Market Segment Percentages, by Type, 2021 (%)

• IDH1 Mutant Medullary Malignant Tumor
• IDH2 Mutant Medullary Malignant Tumor
• Others

Global Isocitrate Dehydrogenase Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Isocitrate Dehydrogenase Inhibitors Market Segment Percentages, by Application, 2021 (%)

• DH Inhibitor
• FLT3 Inhibitor
• Hedgehog Pathway Inhibitor
• Others

Global Isocitrate Dehydrogenase Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Isocitrate Dehydrogenase Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Isocitrate Dehydrogenase Inhibitors revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Isocitrate Dehydrogenase Inhibitors revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AGIOS
• Aslan Pharmaceuticals
• Bayer
• Beigene
• Bristol-Myers Squibb
• Celgene
• Daiichi Sankyo
• Philogen S.p.A.
• Tesaro
• Tragara/Adastra
• Tocagen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Isocitrate Dehydrogenase Inhibitors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Isocitrate Dehydrogenase Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ISOCITRATE DEHYDROGENASE INHIBITORS OVERALL MARKET SIZE

2.1 Global Isocitrate Dehydrogenase Inhibitors Market Size: 2021 VS 2028
2.2 Global Isocitrate Dehydrogenase Inhibitors Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Isocitrate Dehydrogenase Inhibitors Players in Global Market
3.2 Top Global Isocitrate Dehydrogenase Inhibitors Companies Ranked by Revenue
3.3 Global Isocitrate Dehydrogenase Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 Isocitrate Dehydrogenase Inhibitors Companies in Global Market, by Revenue in 2021
3.5 Global Companies Isocitrate Dehydrogenase Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Isocitrate Dehydrogenase Inhibitors Players in Global Market
  3.6.1 List of Global Tier 1 Isocitrate Dehydrogenase Inhibitors Companies
  3.6.2 List of Global Tier 2 and Tier 3 Isocitrate Dehydrogenase Inhibitors Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Isocitrate Dehydrogenase Inhibitors Market Size Markets, 2021 & 2028
  4.1.2 IDH1 Mutant Medullary Malignant Tumor
  4.1.3 IDH2 Mutant Medullary Malignant Tumor
  4.1.4 Others
4.2 By Type - Global Isocitrate Dehydrogenase Inhibitors Revenue & Forecasts
  4.2.1 By Type - Global Isocitrate Dehydrogenase Inhibitors Revenue, 2017-2022
  4.2.2 By Type - Global Isocitrate Dehydrogenase Inhibitors Revenue, 2023-2028
  4.2.3 By Type - Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Isocitrate Dehydrogenase Inhibitors Market Size, 2021 & 2028
  5.1.2 DH Inhibitor
  5.1.3 FLT3 Inhibitor
  5.1.4 Hedgehog Pathway Inhibitor
  5.1.5 Others
5.2 By Application - Global Isocitrate Dehydrogenase Inhibitors Revenue & Forecasts
  5.2.1 By Application - Global Isocitrate Dehydrogenase Inhibitors Revenue, 2017-2022
  5.2.2 By Application - Global Isocitrate Dehydrogenase Inhibitors Revenue, 2023-2028
  5.2.3 By Application - Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Isocitrate Dehydrogenase Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global Isocitrate Dehydrogenase Inhibitors Revenue & Forecasts
  6.2.1 By Region - Global Isocitrate Dehydrogenase Inhibitors Revenue, 2017-2022
  6.2.2 By Region - Global Isocitrate Dehydrogenase Inhibitors Revenue, 2023-2028
  6.2.3 By Region - Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Isocitrate Dehydrogenase Inhibitors Revenue, 2017-2028
  6.3.2 US Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.3.3 Canada Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.3.4 Mexico Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Isocitrate Dehydrogenase Inhibitors Revenue, 2017-2028
  6.4.2 Germany Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.4.3 France Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.4.4 U.K. Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.4.5 Italy Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.4.6 Russia Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.4.7 Nordic Countries Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.4.8 Benelux Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Isocitrate Dehydrogenase Inhibitors Revenue, 2017-2028
  6.5.2 China Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.5.3 Japan Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.5.4 South Korea Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.5.5 Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.5.6 India Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Isocitrate Dehydrogenase Inhibitors Revenue, 2017-2028
  6.6.2 Brazil Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.6.3 Argentina Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue, 2017-2028
  6.7.2 Turkey Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.7.3 Israel Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.7.4 Saudi Arabia Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028
  6.7.5 UAE Isocitrate Dehydrogenase Inhibitors Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AGIOS
  7.1.1 AGIOS Corporate Summary
  7.1.2 AGIOS Business Overview
  7.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Major Product Offerings
  7.1.4 AGIOS Isocitrate Dehydrogenase Inhibitors Revenue in Global Market (2017-2022)
  7.1.5 AGIOS Key News
7.2 Aslan Pharmaceuticals
  7.2.1 Aslan Pharmaceuticals Corporate Summary
  7.2.2 Aslan Pharmaceuticals Business Overview
  7.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Major Product Offerings
  7.2.4 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Revenue in Global Market (2017-2022)
  7.2.5 Aslan Pharmaceuticals Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Major Product Offerings
  7.3.4 Bayer Isocitrate Dehydrogenase Inhibitors Revenue in Global Market (2017-2022)
  7.3.5 Bayer Key News
7.4 Beigene
  7.4.1 Beigene Corporate Summary
  7.4.2 Beigene Business Overview
  7.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Major Product Offerings
  7.4.4 Beigene Isocitrate Dehydrogenase Inhibitors Revenue in Global Market (2017-2022)
  7.4.5 Beigene Key News
7.5 Bristol-Myers Squibb
  7.5.1 Bristol-Myers Squibb Corporate Summary
  7.5.2 Bristol-Myers Squibb Business Overview
  7.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Major Product Offerings
  7.5.4 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Revenue in Global Market (2017-2022)
  7.5.5 Bristol-Myers Squibb Key News
7.6 Celgene
  7.6.1 Celgene Corporate Summary
  7.6.2 Celgene Business Overview
  7.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Major Product Offerings
  7.6.4 Celgene Isocitrate Dehydrogenase Inhibitors Revenue in Global Market (2017-2022)
  7.6.5 Celgene Key News
7.7 Daiichi Sankyo
  7.7.1 Daiichi Sankyo Corporate Summary
  7.7.2 Daiichi Sankyo Business Overview
  7.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Major Product Offerings
  7.7.4 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Revenue in Global Market (2017-2022)
  7.7.5 Daiichi Sankyo Key News
7.8 Philogen S.p.A.
  7.8.1 Philogen S.p.A. Corporate Summary
  7.8.2 Philogen S.p.A. Business Overview
  7.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Major Product Offerings
  7.8.4 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Revenue in Global Market (2017-2022)
  7.8.5 Philogen S.p.A. Key News
7.9 Tesaro
  7.9.1 Tesaro Corporate Summary
  7.9.2 Tesaro Business Overview
  7.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Major Product Offerings
  7.9.4 Tesaro Isocitrate Dehydrogenase Inhibitors Revenue in Global Market (2017-2022)
  7.9.5 Tesaro Key News
7.10 Tragara/Adastra
  7.10.1 Tragara/Adastra Corporate Summary
  7.10.2 Tragara/Adastra Business Overview
  7.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Major Product Offerings
  7.10.4 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Revenue in Global Market (2017-2022)
  7.10.5 Tragara/Adastra Key News
7.11 Tocagen
  7.11.1 Tocagen Corporate Summary
  7.11.2 Tocagen Business Overview
  7.11.3 Tocagen Isocitrate Dehydrogenase Inhibitors Major Product Offerings
  7.11.4 Tocagen Isocitrate Dehydrogenase Inhibitors Revenue in Global Market (2017-2022)
  7.11.5 Tocagen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Isocitrate Dehydrogenase Inhibitors Market Opportunities & Trends in Global Market
Table 2. Isocitrate Dehydrogenase Inhibitors Market Drivers in Global Market
Table 3. Isocitrate Dehydrogenase Inhibitors Market Restraints in Global Market
Table 4. Key Players of Isocitrate Dehydrogenase Inhibitors in Global Market
Table 5. Top Isocitrate Dehydrogenase Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Isocitrate Dehydrogenase Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Isocitrate Dehydrogenase Inhibitors Revenue Share by Companies, 2017-2022
Table 8. Global Companies Isocitrate Dehydrogenase Inhibitors Product Type
Table 9. List of Global Tier 1 Isocitrate Dehydrogenase Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Isocitrate Dehydrogenase Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Isocitrate Dehydrogenase Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Isocitrate Dehydrogenase Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Isocitrate Dehydrogenase Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Isocitrate Dehydrogenase Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 30. AGIOS Corporate Summary
Table 31. AGIOS Isocitrate Dehydrogenase Inhibitors Product Offerings
Table 32. AGIOS Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), (2017-2022)
Table 33. Aslan Pharmaceuticals Corporate Summary
Table 34. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product Offerings
Table 35. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Isocitrate Dehydrogenase Inhibitors Product Offerings
Table 38. Bayer Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), (2017-2022)
Table 39. Beigene Corporate Summary
Table 40. Beigene Isocitrate Dehydrogenase Inhibitors Product Offerings
Table 41. Beigene Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), (2017-2022)
Table 42. Bristol-Myers Squibb Corporate Summary
Table 43. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product Offerings
Table 44. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), (2017-2022)
Table 45. Celgene Corporate Summary
Table 46. Celgene Isocitrate Dehydrogenase Inhibitors Product Offerings
Table 47. Celgene Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), (2017-2022)
Table 48. Daiichi Sankyo Corporate Summary
Table 49. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product Offerings
Table 50. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), (2017-2022)
Table 51. Philogen S.p.A. Corporate Summary
Table 52. Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Product Offerings
Table 53. Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), (2017-2022)
Table 54. Tesaro Corporate Summary
Table 55. Tesaro Isocitrate Dehydrogenase Inhibitors Product Offerings
Table 56. Tesaro Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), (2017-2022)
Table 57. Tragara/Adastra Corporate Summary
Table 58. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product Offerings
Table 59. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), (2017-2022)
Table 60. Tocagen Corporate Summary
Table 61. Tocagen Isocitrate Dehydrogenase Inhibitors Product Offerings
Table 62. Tocagen Isocitrate Dehydrogenase Inhibitors Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Isocitrate Dehydrogenase Inhibitors Segment by Type in 2021
Figure 2. Isocitrate Dehydrogenase Inhibitors Segment by Application in 2021
Figure 3. Global Isocitrate Dehydrogenase Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Isocitrate Dehydrogenase Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Isocitrate Dehydrogenase Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Isocitrate Dehydrogenase Inhibitors Revenue in 2021
Figure 8. By Type - Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share, 2017-2028
Figure 9. By Application - Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share, 2017-2028
Figure 10. By Region - Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Country - North America Isocitrate Dehydrogenase Inhibitors Revenue Market Share, 2017-2028
Figure 12. US Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Isocitrate Dehydrogenase Inhibitors Revenue Market Share, 2017-2028
Figure 16. Germany Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 17. France Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Isocitrate Dehydrogenase Inhibitors Revenue Market Share, 2017-2028
Figure 24. China Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. India Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Isocitrate Dehydrogenase Inhibitors Revenue Market Share, 2017-2028
Figure 30. Brazil Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue Market Share, 2017-2028
Figure 33. Turkey Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Isocitrate Dehydrogenase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. AGIOS Isocitrate Dehydrogenase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Isocitrate Dehydrogenase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Beigene Isocitrate Dehydrogenase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Celgene Isocitrate Dehydrogenase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Tesaro Isocitrate Dehydrogenase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Tocagen Isocitrate Dehydrogenase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)